




Searching News Database: MEDITE
HSMN NewsFeed - 5 Oct 2018
ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism
ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism
HSMN NewsFeed - 4 Oct 2018
Launch of The 4Klear(TM), Native 4K Surgical Microscope Camera with integrated 4K Recording
Launch of The 4Klear(TM), Native 4K Surgical Microscope Camera with integrated 4K Recording
HSMN NewsFeed - 13 Apr 2018
Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
HSMN NewsFeed - 4 Apr 2018
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
Mallinckrodt Names Paul R. Carter, Anne C. Whitaker to its Board of Directors
HSMN NewsFeed - 14 Feb 2017
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing
HSMN NewsFeed - 13 Oct 2016
Carl Zeiss Meditec Appoints Steven C. Schallhorn, MD as Chief Medical Officer
Carl Zeiss Meditec Appoints Steven C. Schallhorn, MD as Chief Medical Officer
HSMN NewsFeed - 8 Aug 2016
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
HSMN NewsFeed - 27 Jul 2016
Carl Zeiss Meditec Recruits James V. Mazzo to Lead its Newly Consolidated Ophthalmology Organization
Carl Zeiss Meditec Recruits James V. Mazzo to Lead its Newly Consolidated Ophthalmology Organization
HSMN NewsFeed - 28 May 2015
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer
HSMN NewsFeed - 3 Mar 2015
Oraya Therapeutics' AMD Radiotherapy Device Receives New Indication of Use for Choroidal Metastases
Oraya Therapeutics' AMD Radiotherapy Device Receives New Indication of Use for Choroidal Metastases
HSMN NewsFeed - 27 Aug 2014
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
Bellicum Pharmaceuticals Secures $55 Million in Oversubscribed Series C Financing
HSMN NewsFeed - 7 Nov 2013
IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales
IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales
HSMN NewsFeed - 22 Oct 2012
FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
FDA Approves New Non-Invasive, Non-Ionizing Radiation Therapy to Treat Pain from Bone Metastases
HSMN NewsFeed - 11 Oct 2012
Carl Zeiss Advances Surgical Visualization with New 3D HD Video System for the OPMI PENTERO Microscope
Carl Zeiss Advances Surgical Visualization with New 3D HD Video System for the OPMI PENTERO Microscope
HSMN NewsFeed - 21 May 2012
Apollo Endosurgery Names Former Covidien Chairman and CEO Richard J. Meelia to Board of Directors
Apollo Endosurgery Names Former Covidien Chairman and CEO Richard J. Meelia to Board of Directors
HSMN NewsFeed - 21 May 2012
AngioDynamics Appoints Experienced Industry Executive as Chief Technology Officer
AngioDynamics Appoints Experienced Industry Executive as Chief Technology Officer
HSMN NewsFeed - 12 Mar 2012
Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy
Given Imaging Announces Publication of Colon Capsule Endoscopy Guidelines in Endoscopy
HSMN NewsFeed - 10 Oct 2011
Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer
Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer
HSMN NewsFeed - 28 Mar 2011
FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
FDA Approves Hyperopia Application for the MEL 80 Excimer Laser from Carl Zeiss Meditec
HSMN NewsFeed - 29 Sep 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
HSMN NewsFeed - 11 Feb 2010
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
HSMN NewsFeed - 18 Jan 2010
Carl Zeiss Meditec Continues Successful Growth Strategy with New Chief Executive Officer
Carl Zeiss Meditec Continues Successful Growth Strategy with New Chief Executive Officer
HSMN NewsFeed - 13 Jan 2010
First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
HSMN NewsFeed - 1 Dec 2009
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
HSMN NewsFeed - 4 Aug 2009
Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
HSMN NewsFeed - 25 Feb 2009
Cynosure Appoints William T. Kelley as Senior Vice President of International Sales
Cynosure Appoints William T. Kelley as Senior Vice President of International Sales
HSMN NewsFeed - 31 Dec 2008
China Medical Technologies Announces the Completion of the Sale of its HIFU Business
China Medical Technologies Announces the Completion of the Sale of its HIFU Business
HSMN NewsFeed - 4 Apr 2008
Carl Zeiss Meditec Delivers Key Technological Advances in Optical Coherence Tomography
Carl Zeiss Meditec Delivers Key Technological Advances in Optical Coherence Tomography
HSMN NewsFeed - 13 Mar 2008
Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
HSMN NewsFeed - 28 Feb 2008
Deal between Freedom Meditech and Battelle Could Lead to Breakthrough in Diabetes Management
Deal between Freedom Meditech and Battelle Could Lead to Breakthrough in Diabetes Management
HSMN NewsFeed - 14 Dec 2007
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
HSMN NewsFeed - 15 Oct 2007
China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System
China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System
HSMN NewsFeed - 27 Sep 2007
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
HSMN NewsFeed - 17 Jul 2007
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
HSMN NewsFeed - 6 Jun 2007
InSightec Receives European CE Mark for ExAblate(R) 2000 Treatment of Pain Caused by Bone Metastases
InSightec Receives European CE Mark for ExAblate(R) 2000 Treatment of Pain Caused by Bone Metastases
HSMN NewsFeed - 29 May 2007
Positive Final Data from HyCAMP(TM) Phase II Trial in Metastatic Colorectal Cancer
Positive Final Data from HyCAMP(TM) Phase II Trial in Metastatic Colorectal Cancer
HSMN NewsFeed - 14 May 2007
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
InSightec Encourages Uterine Fibroid Sufferers to Ask Their Doctors About Less Invasive Treatment Options
HSMN NewsFeed - 30 Apr 2007
3M, Gen-Probe Form Collaboration to Develop Rapid Molecular Tests to Combat Healthcare-Associated Infections
3M, Gen-Probe Form Collaboration to Develop Rapid Molecular Tests to Combat Healthcare-Associated Infections
HSMN NewsFeed - 30 Apr 2007
Carl Zeiss Meditec: Benchmark for Eye Disease Treatment -- Company Ships 15,000th Ophthalmic Laser Worldwide
Carl Zeiss Meditec: Benchmark for Eye Disease Treatment -- Company Ships 15,000th Ophthalmic Laser Worldwide
HSMN NewsFeed - 11 Apr 2007
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
HSMN NewsFeed - 1 Mar 2007
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
FDA Approves New Version of InSightec's ExAblate(R) 2000 That Speeds up Treatment Time
HSMN NewsFeed - 18 Jan 2007
Carl Zeiss Meditec Announces FDA Clearance to Market VISUMAX Femtosecond Laser System
Carl Zeiss Meditec Announces FDA Clearance to Market VISUMAX Femtosecond Laser System
HSMN NewsFeed - 28 Nov 2006
Carl Zeiss Meditec Named Ophthalmologists' First Choice for Optical Biometry
Carl Zeiss Meditec Named Ophthalmologists' First Choice for Optical Biometry
HSMN NewsFeed - 16 Oct 2006
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
HSMN NewsFeed - 22 Aug 2006
Carl Zeiss Meditec Receives FDA Clearance for MEL 80 Excimer Laser Systems
Carl Zeiss Meditec Receives FDA Clearance for MEL 80 Excimer Laser Systems
HSMN NewsFeed - 3 May 2006
New Life Scientific and Biorigen Srl Announce Strategic Alliance Agreement
New Life Scientific and Biorigen Srl Announce Strategic Alliance Agreement
HSMN NewsFeed - 29 Mar 2006
Nanogen Receives 510(k) Clearance for StatusFirst(TM) Congestive Heart Failure NT-proBNP Test
Nanogen Receives 510(k) Clearance for StatusFirst(TM) Congestive Heart Failure NT-proBNP Test
Additional items found! 32

Members Archive contains
32 additional stories matching:
MEDITE
(Password required)
MEDITE
(Password required)